Inspire Medical Systems Inc. falsely touted its preparations for launching a new sleep apnea device, customer demand for the product, and initial successes before reporting sluggish sales, an investor ...

Inspire Medical Systems, which produces an implant to treat sleep apnea, extended the run spots involving the Golden Bachelorette winner through the holidays.

Inspire Medical (NYSE: INSP) shares got a boost after hours today on third-quarter results that beat the consensus Wall ...

Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees' Retirement System against Inspire Medical Systems, Inc. ("Inspire Medical" or ...

Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...

Investors have filed a class action complaint against Inspire Medical (NYSE:INSP) alleging violations of federal securities ...

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, ...

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Inspire Medical Systems, Inc. common stock between August 6, 2024 and ...

Inspire (INSP) delivered earnings and revenue surprises of +353.33% and +1.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems Inc. (INSP) on Monday reported third-quarter earnings of $9.9 million. On a per-share basis, the Golden ...

The Russell 2000® Growth Index was up 12.19%. The Wasatch Small Cap Growth Fund—Investor Class (WAAEX) did not keep pace and ...

Medical technology company Inspire Medical Systems (NYSE:INSP) in Q3 CY2025, with sales up 10.5% year on year to $224.5 ...